Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Average Recommendation of “Hold” from Brokerages

Mereo BioPharma Group plc - Sponsored ADR (NASDAQ: MREO - Get Free Report) has earned a consensus recommendation of "Hold" from the eight analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and three have issued a buy recommendation on